Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer

By Salatino Mariana   Croci Diego O   Bianco Germán A   Ilarregui Juan M   Toscano Marta A   Rabinovich Gabriel A  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 45-57

Informa Healthcare

Access to resources Recommend Favorite

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J   Lui Vivian Wai Yan   Grandis Jennifer Rubin  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Galectin-8 and galectin-9 are novel substrates for thrombin

By Nishi Nozomu   Itoh Aiko   Shoji Hiroki   Miyanaka Hiroshi   Nakamura Takanori  

Glycobiology, Vol. 16, Iss. 11, 2006-11 ,pp. : 15-20

Oxford University Press

Access to resources Recommend Favorite

Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis

By Rabinovich Gabriel A.   Cumashi Albana   Bianco Germán A.   Ciavardelli Domenico   Iurisci Ida   D’Egidio Maurizia   Piccolo Enza   Tinari Nicola   Nifantiev Nikolay   Iacobelli Stefano  

Glycobiology, Vol. 16, Iss. 3, 2006-03 ,pp. : 210-220

Oxford University Press

Access to resources Recommend Favorite

Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3

By Ahmad Nisar  

Glycobiology, Vol. 14, Iss. 9, 2004-09 ,pp. : 817-825

Oxford University Press

Access to resources Recommend Favorite